PetCaseFinder

Peer-reviewed veterinary case report

Loss of glutamine synthetase in the retina of dogs

By Chen, Chu-Te et al.·Published in Veterinary ophthalmology·2008·Department of Clinical Sciences, United States·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Loss of glutamine synthetase immunoreactivity from the retina in canine primary glaucoma.

Species:
dog

Plain-English summary

A study looked at dogs with primary glaucoma, a condition that can cause vision problems, to understand changes happening in their retinas. Researchers found that a protein called glutamine synthetase, which helps manage glutamate (a neurotransmitter), was less active in the retinas of affected dogs. This decrease was linked to damage in the retinal cells and changes in glutamate distribution. The findings suggest that lower levels of this protein may worsen the damage caused by glaucoma. Unfortunately, the study does not provide specific treatments or outcomes for the dogs involved.

People also search for: dog glaucoma symptoms · canine retinal damage treatment · primary glaucoma in dogs

Abstract

PURPOSE: Changes in retinal glutamate distribution occur in primary glaucoma (PG) in dogs. Although the redistribution resembles that induced by ischemia, decreases in glutamine synthetase (GS) activity may also induce a similar glutamate redistribution. We examined the distribution of GS, glutamate, and glial fibrillary acidic protein (GFAP), a marker for reactive glia, in PG retinas by immunohistochemistry to determine whether decreases in GS and formation of reactive glia are associated with glutamate redistribution and neuronal damage. ANIMALS: Sections from 14 control dog eyes and 22 eyes from dogs with PG. METHODS: Sections from 14 control and 22 glaucomatous globes were immunohistochemically stained for GS, glial fibrillary acidic protein or glutamate. RESULTS: In semiquantitative immunogold studies, decreases in GS staining density were strongly correlated with glutamate redistribution and neuronal damage. In less quantitative immunoperoxidase staining of acute (< or = 5 days after clinical signs) and chronic PG retinas, GS immunoreactivity was decreased in focal regions of some acute PG retinas, and there were widespread decreases in chronic PG retinas. GFAP immunoreactivity was increased in M&#xfc;ller cells primarily in severely damaged regions of chronic PG retinas. CONCLUSIONS: Decreases in GS immunoreactivity were associated with glutamate redistribution. These decreases in GS occurred even in mildly damaged regions of retina before retinal thinning. Reactive M&#xfc;ller cells were seen primarily in chronic PG in severely damaged regions. Decreases in GS may potentiate ischemia-induced early glutamate redistribution and neuronal damage in canine PG.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/18435655/